Canadian biopharma companies are capitalizing on increased government investment stimulated by the recent pandemic to strengthen domestic capabilities and foster multinational partnerships that enhance drug discovery and development worldwide. Canada has long punched above its weight in life sciences and biotechnology, with many of the fundamental discoveries that underpin today’s important blockbuster drugs and therapeutic […]
drug companies
Ontario delays implementation of pharma transparency rules
The Ontario government is putting off the implementation of rules that would require pharmaceutical companies and medical device makers to report all payments and gifts to doctors, medical associations, patient advocacy groups and others in the province. The Health Sector Payment Transparency Act was passed in December 2017, but the regulations had not been finalized […]